A program led by Duke University School of Medicine students is helping people who have a history of homelessness make the transition to stable housing easier. In the process, the students are gaining a better understanding of the impact housing can have on health.

Emily Wang, MD'03, is a professor of internal medicine and public health at the Yale School of Medicine and Yale School of Public Health.

Denise Jamieson, MD'92, MPH, is vice president for medical affairs and dean of the Carver College of Medicine at the University of Iowa.

Barton F. Haynes, MD, HS’73-’75, is the Frederic M. Hanes Distinguished Professor of Medicine, professor of integrative immunology and global health and, for 34 years, director of the Duke Human Vaccine Institute (DHVI). He is an internationally recognized researcher who has expanded our understanding of fundamental immune regulation and its role in disease pathogenesis and vaccine development. Haynes’s early work on the biology of the thymus led to discoveries with Louise Markert, PhD’81, MD’82, HS’82-’87, that enabled successful thymus transplantation in children born without a thymus.

Tony Coles, MD’86, has served since 2018 as chair of the board of directors for Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neurological diseases.

Kenneth Poss, PhD, is the James B. Duke Distinguished Professor of Regenerative Biology in the Department of Cell Biology at Duke University School of Medicine

Gregory Georgiade, MD'74, HS'73-'78, HS'78-'80, is a professor of surgery in the Division of Plastic, Maxillofacial, and Oral Surgery in the Department of Surgery at Duke University School of Medicine.

A record number of medical alumni (more than 500) came back for Duke Medical Alumni Weekend, held Nov. 9-12, 2023. Events included the Distinguished Awardee Dinner, various receptions, lectures, tours, class dinners, dancing, and much, much more.

Clinicians, researchers, and educators at Duke University School of Medicine and across Duke Health are using artificial intelligence (AI) to schedule surgeries more efficiently, give students immediate feedback on academic writing, and help speed up drug discovery. Duke is at the leading edge of efforts to maximize the benefits of AI in health care while putting effective guardrails in place to minimize potential risks. “We have a huge potential to reduce physician burden, increase health care efficiency, and improve the patient experience,” said Michael Pencina, PhD, director of Duke AI Health and chief data scientist for Duke Health. “But we need to be very intentional about what AI will be doing.”

School of Medicine faculty are using the capabilities of ChatGPT, a chatbot that answers questions and generates text using natural language processing, to improve students’ learning experiences and assist with their own research. At the same time, they caution that monitoring and fact-checking the system are essential.